NCT03294811 (CardioCoach) is a NA clinical trial of Telemonitoring in Heart Failure, sponsored by Hasselt University.

Who is sponsoring NCT03294811?

NCT03294811 is sponsored by Hasselt University.

What drugs are being tested in NCT03294811?

Interventions in NCT03294811: Telemonitoring.

What condition does NCT03294811 study?

NCT03294811 studies Heart Failure.

Is NCT03294811 still recruiting?

NCT03294811 is currently completed. Last updated 13 May 2019.

Last reviewed 2019-05-13 · How we verify

NCT03294811: CardioCoach

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Two-way Communication System to Coach Elderly Patients With Heart Failure

Completed NA Last updated 13 May 2019

What this trial tests

NA trial testing Telemonitoring in Heart Failure in 25 participants. Completed in 4 April 2018.

Timeline

1 May 2014

Primary endpoint
15 December 2016

4 April 2018

Quick facts

Lead sponsor	Hasselt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	25
Start date	1 May 2014
Primary completion	15 December 2016
Estimated completion	4 April 2018
Sites	2 locations across Belgium

Drugs / interventions tested

Telemonitoring

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

Hasselt University

Who can join

60 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open randomized clinical trial with two study arms. One group, receiving usual care for heart failure, will be compared to another group, receiving usual care plus active telemonitoring interference. When leaving the hospital, the usual care arm receives a document with a predefined medication scheme and advice for the general practitioner (like it is currently done in usual care). The telemonitoring interference in the other study arm consists of a smartphone application to register medication intake and to transmit the data of an automatic blood pressure device and a balance to a central platform. The goal is to improve medication uptitration (angiotensin-converting-enzyme inhibitor (ACE-I) and bètablockers (BB)) in heart failure patients and to improve medication compliance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Novel Intelligent Two-Way Communication System for Remote Heart Failure Medication Uptitration (the CardioCoach Study): Randomized Controlled Feasibility Trial.
Smeets CJ, Storms V, Vandervoort PM, Dreesen P, et al · · 2018 · cited 10× · PMID 31758773 · DOI 10.2196/cardio.9153

Verify or expand the search:

Other trials of Telemonitoring

Trials testing the same drug.

NCT06713811 — Evaluation of the Impact of Electronic Monitoring on Patient Compliance in Hematology · NA · recruiting
NCT07174206 — FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection · NA · recruiting
NCT06331416 — Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation · NA · recruiting
NCT06240637 — Telemonitoring Utility in the Process of Adaptation to Home Mechanical Ventilation (HMV) · NA · recruiting
NCT07049289 — Telemonitoring in Arterial Hypertension · NA · active not recruiting

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Hasselt University trials

Trials by the same sponsor.

NCT07419100 — Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health · NA · not yet recruiting
NCT07505355 — Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis · recruiting
NCT07081893 — How do Patients, Relatives and Healthcare Professionals View Person-centered Rehabilitation. · not yet recruiting
NCT06785909 — Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain. · NA · recruiting
NCT07175792 — Accuracy of Motor Performance Perception in Multiple Sclerosis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03294811 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hasselt University
Last refreshed: 13 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03294811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing